up to now several years, the united kingdom has witnessed a revolution in professional medical excess weight‑reduction treatment plans — from the introduction of semaglutide (Wegovy®) towards the developing level of popularity of tirzepatide (Mounjaro®). Now, another identify is drawing focus in